UnitedHealth $UNH ( ▼ 0.59% ) shares tumbled after the health insurance giant issued a weaker-than-expected 2026 forecast, adding to pressure already building across the sector. The company is the first major insurer to report this earnings season, and its guidance set an uneasy tone.
Guidance is the real problem
While fourth-quarter results were mostly in line with expectations, the outlook is what rattled Wall Street. UnitedHealth said it expects 2026 revenue to come in above $439 billion, which would mark a 2% decline from last year and fall well short of analyst forecasts near $454 billion. The company also projected adjusted earnings per share just above $17.75, roughly in line with estimates but not strong enough to offset concerns about slowing growth.
Management said the revenue dip is tied to “right-sizing” efforts, including a planned decline in membership and a pullback in its Optum Health care delivery unit. Medicare Advantage membership alone is expected to fall by about 1.4 million people.
Washington is squeezing insurers
The weaker forecast comes as the federal government signals tighter conditions for Medicare insurers. A proposal to keep Medicare reimbursement rates roughly flat next year, combined with stricter rules around how patient risk scores are calculated, could pressure margins across the industry. UnitedHealth executives said they plan to push back, arguing current proposals do not reflect rising medical costs and utilization trends.
Higher healthcare expenses have already been eating into profitability. UnitedHealthcare’s medical cost ratio climbed sharply last year, meaning a larger share of premiums is going toward paying claims rather than generating profit.
Industry headwinds are piling up
Beyond Medicare pressure, insurers are also dealing with fallout from the expiration of enhanced Affordable Care Act subsidies. As healthier customers drop coverage due to higher premiums, the remaining insurance pool skews sicker and more expensive, driving up costs for everyone.
On top of that, UnitedHealth $UNH ( ▼ 0.59% ) is navigating civil and criminal investigations tied to its Medicare billing practices. With regulatory scrutiny rising and cost pressures mounting, investors are bracing for a tougher environment not just for UnitedHealth, but for the entire managed care sector.